Microbiota-myeloid cell crosstalk beyond the gut

Area of Science:

• Microbiology
• Immunology
• Host-Microbe Interactions

Background:

• The gut microbiota is a complex ecosystem crucial for host physiology, including immunity and metabolism.
• Gut microbes influence systemic immunity, but mechanisms linking gut microbiota and systemic immune cells are unclear.
• Myeloid cells are key responders to microbial signals, bridging innate and adaptive immunity.

Purpose of the Study:

• To review the impact of gut microbiota on myeloid cells at extraintestinal sites.
• To explore how commensal-derived signals influence myeloid cell function and host responses.
• To understand the role of gut microbiota in modulating responses to infection and cancer therapy.

Main Methods:

• Review of existing literature on gut microbiota and myeloid cell interactions.
• Focus on commensal-derived signals and their effects on extraintestinal myeloid cells.
• Analysis of how these interactions influence immunity, infection, and cancer therapy outcomes.

Main Results:

• Gut microbiota significantly impacts myeloid cell development and function in extraintestinal sites.
• Commensal signals modulate steady-state myelopoiesis and cellular responses.
• These microbiota-driven changes affect host defense against infection and efficacy of cancer therapy.

Conclusions:

• The gut microbiota plays a critical role in shaping extraintestinal myeloid cell immunity.
• Understanding these interactions is vital for developing novel therapeutic strategies.
• Targeting the gut microbiota may enhance host defense and cancer treatment outcomes.